NexImmune, Inc. NEXI
0.00
0.00
NaN
as of 24 Sep
- Market cap
- $1.6M
- P/E
- 0.0×
Follow NEXI
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '23 | Dec '23 | Mar '24 | Jun '24 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
1.66 | 1.06 | 1.30 | 0.66 |
Net Debt/EBITDA |
0.88 | 0.63 | 1.69 | 0.71 | |
Debt/Assets |
3.45% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.06 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.74 | 1.09 | 0.79 | 0.89 | |
Capex/Depreciation |
0.01 | 0.00 | 4.55 | 0.58 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(6.95) | (5.56) | (1.51) | (1.47) | |
Cash per Share |
8.64 | 3.07 | 3.58 | 1.77 | |
Shareholders Equity per Share |
7.88 | 3.34 | 2.19 | 0.50 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.88 | 3.34 | 2.19 | 0.50 | |
Free Cash Flow |
(7.28) | (5.83) | (1.89) | (2.03) | |
Working Capital |
4.12 | 0.32 | 1.41 | (1.61) | |
Capital Expenditures |
0.00 | 0.00 | 0.52 | 0.04 | |
Net Current Asset Value |
4.01 | 0.32 | (0.21) | (2.04) | |
| Other line items | |||||
Quick Ratio |
1.46 | 0.63 | 0.97 | 0.52 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(6.95) | (5.56) | (1.93) | (1.50) | |
Capex per Share |
0.00 | 0.00 | 0.42 | 0.03 | |
Average Payables |
1.00 | 1.86 | 0.71 | 0.93 | |
Average Assets |
36.12 | 25.83 | 19.83 | 14.67 | |
Average Common Equity |
27.98 | 17.91 | 13.16 | 8.85 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates